Position in IONS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$118,268,476
+$13,736,874 QoQ
Shares Held
1,575,023
+19.2% QoQ
Ownership
0.953%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 99.88070015485488.ToString("F0")%
Shared 0.ToString("F0")%
None 0.11929984514511853.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. IONS ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in IONS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,268,476 | 1,575,023 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $104,531,602 | 1,321,345 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $431,313 | 6,593 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $219,516 | 5,556 | Shares | Defined | 2025-08-12 | |
| 2024-12-31 | $465,002 | 13,301 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $406,807 | 10,155 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $477,647 | 10,022 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $425,218 | 9,809 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $693,335 | 13,705 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $383,246 | 8,449 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $376,285 | 9,171 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $371,695 | 10,400 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $518,165 | 13,719 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $497,631 | 11,251 | Shares | Defined | 2022-11-14 | |
| 2020-12-31 | $208,179 | 3,682 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $11,499,554 | 242,351 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $14,163,960 | 240,230 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $11,379,018 | 240,673 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||